Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
CYB-004 by Cybin for Social Anxiety Disorder (SAD/Social Phobia): Likelihood of Approval
CYB-004 is under clinical development by Cybin and currently in Phase I for Social Anxiety Disorder (SAD/Social Phobia). According to...
Data Insights
CYB-004 by Cybin for Generalized Anxiety Disorder (GAD): Likelihood of Approval
CYB-004 is under clinical development by Cybin and currently in Phase II for Generalized Anxiety Disorder (GAD). According to GlobalData,...